Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
Woo, P., Wilkinson, N., Prieur, A-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D. and Kishimoto, T.
(2005)
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
Arthritis Research and Therapy, 7 (6).
ISSN 1478-6354
| Item Type | Article |
|---|---|
| Additional information | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Original article can be found at: http://arthritis-research.com/ |
| Date Deposited | 15 May 2025 11:43 |
| Last Modified | 30 May 2025 23:36 |
-
picture_as_pdf - 901524.pdf
Share this file
Downloads